Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab or placebo plus platinum-based chemotherapy in resectable stage II-IIIA/select IIIB NSCLC
CTR20181628Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of atezolizumab in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Jan 2020; status: completed.
02
Drugs
atezolizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20181628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181628.